Vaccine, Preventive Strategies and Antiviral Responses to Zoonotic Viruses

Dear Colleagues,

We are now facing a world increasingly affected by viral zoonoses entering the human society, among which Ebola virus disease, COVID-19, avian influenza and Mpox are notable examples. Vaccines remain the top priority for preventing infectious diseases, yet many viral zoonotic pathogens, especially emerging ones, lack licensed vaccines.

This Special Issue aims to publish recent progress on vaccine development and efficacy evaluation, immune responses and immunologic mechanisms, as well as development of animal models against various zoonotic viral pathogens. Those include numerous viral pathogens that are characterized by different taxonomic categories, including Alphavirus, Arenavirus, Bunyavirus, Coronavirus, Flavivirus, Filovirus, Orthopoxvirus, Orthomyxovirus, Paramyxovirus, Rhabdovirus, etc.

For this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following areas:

• Animal models for viral zoonoses;
• Vaccine development and efficacy evaluation for viral zoonoses;
• Immune responses to vaccines and the underlying immunologic mechanisms;
• Adjuvants and immunomodulators for vaccines;
• Next-generation vaccine technology;
• Clinical trials of vaccines;
• Epidemiology and significance of viral mutation for vaccine efficacy.

We look forward to receiving your contributions.

Dr. Wei Ye
Dr. Shu Shen
Prof. Dr. Chen Peng
Dr. Ben Hu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.